Freespira, Inc. was recently featured in Next Steps for Digital Therapeutics Market: Global Leaders Share Views on Permanency and Adoption published by Chief Healthcare Executive written by Megan Coder, Pharm.D., M.B.A., Executive Director, Digital Therapeutics Alliance.
Coder goes on to reflect on 2020 and organizations who made strides in the digital therapeutic industry. Along with several other organizations, she recognizes Freespira for making significant process in 2020 in demonstrated outcomes and the investment landscape.
